Early Phase 1 HCC Clinical Trials

3 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–3 of 3 trials

Recruiting

Early Phase 1

Universal CAR-T Cells (REVO-UWD-03) for Advanced Hepatocellular Carcinoma and Lung Cancer

NSCLC (Advanced Non-small Cell Lung Cancer)HCC - Hepatocellular Carcinoma

Wondercel Biotech (ShenZhen)60 enrolled2 locationsNCT06653023

Recruiting

Early Phase 1

Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC)

Hepatocellular Carcinoma (HCC)

Koo Foundation Sun Yat-Sen Cancer Center43 enrolled4 locationsNCT04601428

Recruiting

Early Phase 1

Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC)

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine12 enrolled1 locationNCT06652243